Bioelectronics Corp (BIEL)

[kidnova]

IMO, this reclass application in response to the FDA's proposed rulemaking is BIEL's last shot at FDA approval. If they are denied then it's down to a PMA which is an expensive and time consuming process. At some point it would be best for Whelan to sell the patents and stop wasting shareholder money. I do not think they will thrive overseas without the FDA stamp of approval, personally.